Know Cancer

or
forgot password


N/A
17 Years
60 Years
Not Enrolling
Female
Cervical Cancer

Thank you

Trial Information


Inclusion Criteria:



1. FIGO(2009) stage Ia2, Ib1, and IIa1 Untreated cervical cancer OR FIGO(2009) stage
Ib2 and IIa2 cervical cancer that possible to surgery after neoadjuvant chemotherapy

2. Possible to radical hysterectomy or nerve-spring radical hysterectomy

3. Age: 17 to 60 years

4. No complication during operation

5. Written informed consent

Exclusion Criteria:

1. patients who underwent radiotherapy

2. Pathologically diagnosed Pathologically diagnosed squamous carcinoma, Small Cell
Carcinoma, Small Cell Carcinoma

3. Patients who have uncontrolled diabetes or uncontrolled hypertension

4. patients with neurogenic bladder dysfunction

5. patients with uterine prolapse

6. Patients with psychiatric illness

7. Patients who have active infection

8. Patients who have had heart failure, unstable angina, or myocardial infarction within
the past 6 months

9. Patients who are unable to undergo radical hysterectomy for complication of excessive
obesity, liver cirrhosis, or bleeding tendency

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Outcome Measure:

maximum flow rate measured by Urodynamic at 6 months postoperative

Outcome Time Frame:

on 6 months postoperative

Safety Issue:

No

Authority:

China: Ministry of Health

Study ID:

NCT00270426

NCT ID:

NCT01886508

Start Date:

July 2013

Completion Date:

December 2020

Related Keywords:

  • Cervical Cancer
  • Uterine Cervical Neoplasms

Name

Location